NYSE - Delayed Quote • USD
ResMed Inc. (RMD)
At close: May 17 at 4:00 PM EDT
After hours: May 17 at 6:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 9 | 4 | 12 | 12 |
| Avg. Estimate | 2.06 | 2 | 7.73 | 8.63 |
| Low Estimate | 1.97 | 1.94 | 7.62 | 8.25 |
| High Estimate | 2.2 | 2.09 | 7.89 | 9.29 |
| Year Ago EPS | 1.6 | 1.64 | 6.44 | 7.73 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 12 | 4 | 16 | 16 |
| Avg. Estimate | 1.21B | 1.17B | 4.68B | 5.01B |
| Low Estimate | 1.18B | 1.14B | 4.65B | 4.89B |
| High Estimate | 1.25B | 1.18B | 4.72B | 5.13B |
| Year Ago Sales | 1.12B | 1.1B | 4.22B | 4.68B |
| Sales Growth (year/est) | 8.30% | 6.40% | 10.80% | 7.20% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 1.69 | 1.62 | 1.8 | 1.91 |
| EPS Actual | 1.6 | 1.64 | 1.88 | 2.13 |
| Difference | -0.09 | 0.02 | 0.08 | 0.22 |
| Surprise % | -5.30% | 1.20% | 4.40% | 11.50% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 2.06 | 2 | 7.73 | 8.63 |
| 7 Days Ago | 2.06 | 2 | 7.73 | 8.63 |
| 30 Days Ago | 1.96 | 1.91 | 7.41 | 8.18 |
| 60 Days Ago | 1.96 | 1.91 | 7.45 | 8.13 |
| 90 Days Ago | 1.96 | 1.91 | 7.45 | 8.13 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 11 | 5 | 13 | 13 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | RMD | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 28.70% | -- | -- | 8.00% |
| Next Qtr. | 22.00% | -- | -- | 12.40% |
| Current Year | 20.00% | -- | -- | 5.60% |
| Next Year | 11.60% | -- | -- | 13.00% |
| Next 5 Years (per annum) | 13.00% | -- | -- | 11.14% |
| Past 5 Years (per annum) | 13.89% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Oppenheimer: Outperform to Outperform | 4/26/2024 |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 4/26/2024 |
| Maintains | Keybanc: Overweight to Overweight | 4/26/2024 |
| Maintains | Needham: Buy to Buy | 4/26/2024 |
| Maintains | Needham: Buy to Buy | 4/1/2024 |
| Maintains | Mizuho: Buy to Buy | 3/27/2024 |
Related Tickers
WST West Pharmaceutical Services, Inc.
355.64
+0.43%
ALC Alcon Inc.
88.83
-0.26%
BDX Becton, Dickinson and Company
236.30
-0.14%
TFX Teleflex Incorporated
217.64
-0.43%
COO The Cooper Companies, Inc.
97.31
-0.60%
BAX Baxter International Inc.
35.25
+0.23%
ISRG Intuitive Surgical, Inc.
398.82
+0.60%
HAE Haemonetics Corporation
95.73
+0.98%
RGEN Repligen Corporation
171.94
+0.53%
ICUI ICU Medical, Inc.
103.99
-2.15%